{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:17:36Z","timestamp":1782253056291,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1F1A1063053"],"award-info":[{"award-number":["NRF-2019R1F1A1063053"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to evaluate the relationship between chronic rhinosinusitis (CRS) and proton pump inhibitor (PPI) use in a Korean population. The Korea National Health Insurance Service-National Sample Cohort was assessed from 2002 to 2013. Patients with CRS (<jats:italic>n<\/jats:italic>\u2009=\u20097194) and control participants (<jats:italic>n<\/jats:italic>\u2009=\u200928,776) were matched by random order at a 1:4 ratio for age, sex, income group, region of residence, and index date. We analyzed PPI use by patients with and without CRS. ICD-10 codes defined CRS, and claim codes defined previous PPI use. Conditional logistic regression analyzed the crude and adjusted odds ratios (ORs) with 95% confidence intervals (CI). Subgroup analyses were performed according to age and sex. There was a difference in PPI prescription history and prescription duration between the CRS and control groups. The rate of CRS was higher in current (33.8% [263\/778]) and past (26.3% [713\/2708]) PPI users than PPI non-users (19.1% [6218\/32,484], <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The adjusted OR (aOR) of CRS with\/without nasal polyps was 1.71 (95% CI 1.46\u20132.02, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and 1.28 (95% CI 1.16\u20131.41, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) in current and past PPI users, respectively. Irrespective of PPI prescription days, PPI use was associated with higher CRS occurrence (aOR 1.46; 95% CI 1.26\u20131.69, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) in the 30\u201389-day PPI user group. The subgroup analyses results were consistent. The ORs of CRS were higher in PPI users than in the controls, and consistently so in all age and sex groups.<\/jats:p>","DOI":"10.1038\/s41598-022-13271-5","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T10:05:00Z","timestamp":1654855500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association between chronic rhinosinusitis and proton pump inhibitor use: a nested case\u2013control study using a health screening cohort"],"prefix":"10.1038","volume":"12","author":[{"given":"Hyo Geun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Gyu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"13271_CR1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/gut.2004.051821","volume":"54","author":"J Dent","year":"2005","unstructured":"Dent, J., El-Serag, H. B., Wallander, M. A. & Johansson, S. Epidemiology of gastrooesophageal reflux disease: A systematic review. Gut 54, 710\u2013717. https:\/\/doi.org\/10.1136\/gut.2004.051821 (2005).","journal-title":"Gut"},{"key":"13271_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1440-1746.2011.06921.x","volume":"27","author":"KM Kim","year":"2012","unstructured":"Kim, K. M. et al. Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: A national population-based study. J. Gastroenterol. Hepatol. 27, 741\u2013745. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06921.x (2012).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"13271_CR3","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","volume":"66","author":"D Hastan","year":"2011","unstructured":"Hastan, D. et al. Chronic rhinosinusitis in Europe\u2014An underestimated disease. A GA(2)LEN study. Allergy 66, 1216\u20131223. https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02646.x (2011).","journal-title":"Allergy"},{"key":"13271_CR4","first-page":"1","volume":"10","author":"JR Pleis","year":"2006","unstructured":"Pleis, J. R. & Lethbridge-Cejku, M. Summary health statistics for U.S. adults: National Health Interview Survey, 2005. Vital Health Stat. 10, 1\u2013153 (2006).","journal-title":"Vital Health Stat."},{"key":"13271_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4193\/Rhino15.157","volume":"54","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. et al. Prevalence and risk factors of chronic rhinosinusitis in South Korea according to diagnostic criteria. Rhinology 54, 329\u2013335. https:\/\/doi.org\/10.4193\/Rhino15.157 (2016).","journal-title":"Rhinology"},{"key":"13271_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2500\/ajra.2011.25.3630","volume":"25","author":"YS Kim","year":"2011","unstructured":"Kim, Y. S. et al. Prevalence and risk factors of chronic rhinosinusitis in Korea. Am. J. Rhinol. Allergy 25, 117\u2013121. https:\/\/doi.org\/10.2500\/ajra.2011.25.3630 (2011).","journal-title":"Am. J. Rhinol. Allergy"},{"key":"13271_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/s0016-5085(97)70168-9","volume":"113","author":"HB El-Serag","year":"1997","unstructured":"El-Serag, H. B. & Sonnenberg, A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 113, 755\u2013760. https:\/\/doi.org\/10.1016\/s0016-5085(97)70168-9 (1997).","journal-title":"Gastroenterology"},{"key":"13271_CR8","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1053\/gast.2001.29545","volume":"121","author":"HB El-Serag","year":"2001","unstructured":"El-Serag, H. B., Gilger, M., Kuebeler, M. & Rabeneck, L. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology 121, 1294\u20131299. https:\/\/doi.org\/10.1053\/gast.2001.29545 (2001).","journal-title":"Gastroenterology"},{"key":"13271_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4193\/Rhin16.177","volume":"55","author":"SR Leason","year":"2017","unstructured":"Leason, S. R. et al. Association of gastro-oesophageal reflux and chronic rhinosinusitis: Systematic review and meta-analysis. Rhinology 55, 3\u201316. https:\/\/doi.org\/10.4193\/Rhin16.177 (2017).","journal-title":"Rhinology"},{"key":"13271_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4193\/Rhin16.275","volume":"55","author":"EJ Katle","year":"2017","unstructured":"Katle, E. J., Hatlebakk, J. G., Grimstad, T., Kvaloy, J. T. & Steinsvag, S. K. Gastro-oesophageal reflux in patients with chronic rhino-sinusitis investigated with multichannel impedance\u2014pH monitoring. Rhinology 55, 27\u201333. https:\/\/doi.org\/10.4193\/Rhin16.275 (2017).","journal-title":"Rhinology"},{"key":"13271_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/alr.22259","volume":"9","author":"SY Kim","year":"2019","unstructured":"Kim, S. Y. et al. Gastroesophageal reflux disease increases the risk of chronic rhinosinusitis: A nested case-control study using a national sample cohort. Int. Forum Allergy Rhinol. 9, 357\u2013362. https:\/\/doi.org\/10.1002\/alr.22259 (2019).","journal-title":"Int. Forum Allergy Rhinol."},{"key":"13271_CR12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/00005537-199704000-00014","volume":"107","author":"DW Chambers","year":"1997","unstructured":"Chambers, D. W., Davis, W. E., Cook, P. R., Nishioka, G. J. & Rudman, D. T. Long-term outcome analysis of functional endoscopic sinus surgery: Correlation of symptoms with endoscopic examination findings and potential prognostic variables. Laryngoscope 107, 504\u2013510. https:\/\/doi.org\/10.1097\/00005537-199704000-00014 (1997).","journal-title":"Laryngoscope"},{"key":"13271_CR13","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil, N. et al. The montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am. J. Gastroenterol. 101, 1900\u20131920. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00630.x (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"13271_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaci.2009.06.023","volume":"124","author":"JR Cortes","year":"2009","unstructured":"Cortes, J. R. et al. Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma. J. Allergy Clin. Immunol. 124, 607\u2013610. https:\/\/doi.org\/10.1016\/j.jaci.2009.06.023 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"13271_CR15","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","volume":"62","author":"E Cheng","year":"2013","unstructured":"Cheng, E. et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 62, 824\u2013832. https:\/\/doi.org\/10.1136\/gutjnl-2012-302250 (2013).","journal-title":"Gut"},{"key":"13271_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaci.2016.07.020","volume":"139","author":"JY Min","year":"2017","unstructured":"Min, J. Y. et al. Proton pump inhibitors decrease eotaxin-3\/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H, K-ATPase. J. Allergy Clin. Immunol. 139, 130. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.020 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"13271_CR17","unstructured":"The National Health Insurance Sharing Service. http:\/\/nhiss.nhis.or.kr\/. (Accessed 5 November 2021)."},{"key":"13271_CR18","doi-asserted-by":"publisher","first-page":"W375","DOI":"10.7326\/0003-4819-149-6-200809160-00005","volume":"149","author":"M Sarkar","year":"2008","unstructured":"Sarkar, M., Hennessy, S. & Yang, Y. X. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann. Intern. Med. 149, W375. https:\/\/doi.org\/10.7326\/0003-4819-149-6-200809160-00005 (2008).","journal-title":"Ann. Intern. Med."},{"key":"13271_CR19","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jaip.2019.10.043","volume":"8","author":"SY Kim","year":"2020","unstructured":"Kim, S. Y., Min, C., Oh, D. J. & Choi, H. G. Bidirectional association between GERD and asthma: Two longitudinal follow-up studies using a national sample cohort. J. Allergy Clin Immnol.-Pract. 8, 1005. https:\/\/doi.org\/10.1016\/j.jaip.2019.10.043 (2020).","journal-title":"J. Allergy Clin Immnol.-Pract."},{"key":"13271_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61240-7","author":"SY Kim","year":"2020","unstructured":"Kim, S. Y., Oh, D. J., Park, B. & Choi, H. G. Bell\u2019s palsy and obesity, alcohol consumption and smoking: A nested case-control study using a national health screening cohort. Sci. Rep. U.K. https:\/\/doi.org\/10.1038\/s41598-020-61240-7 (2020).","journal-title":"Sci. Rep. U.K."},{"key":"13271_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"HD Quan","year":"2011","unstructured":"Quan, H. D. et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 173, 676\u2013682. https:\/\/doi.org\/10.1093\/aje\/kwq433 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"13271_CR22","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.jaip.2021.04.014","volume":"9","author":"JH Kim","year":"2021","unstructured":"Kim, J. H. et al. Association between statin medication and asthma\/asthma exacerbation in a national health screening cohort. J. Allergy Clin. Immnol.-Pract. 9, 2783\u20132791. https:\/\/doi.org\/10.1016\/j.jaip.2021.04.014 (2021).","journal-title":"J. Allergy Clin. Immnol.-Pract."},{"key":"13271_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18094536","author":"SY Kim","year":"2021","unstructured":"Kim, S. Y., Lee, C. H., Yoo, D. M., Min, C. Y. & Choi, H. G. Association between chronic obstructive pulmonary disease and Meniere\u2019s disease: A nested case-control study using a National Health Screening Cohort. Int. J. Environ. Res. Public Health. https:\/\/doi.org\/10.3390\/ijerph18094536 (2021).","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"13271_CR24","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1111\/all.12256","volume":"68","author":"S Kim","year":"2013","unstructured":"Kim, S. et al. Healthcare use and prescription patterns associated with adult asthma in Korea: Analysis of the NHI claims database. Allergy 68, 1435\u20131442. https:\/\/doi.org\/10.1111\/all.12256 (2013).","journal-title":"Allergy"},{"key":"13271_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2466-13-51","volume":"13","author":"J Kim","year":"2013","unstructured":"Kim, J. et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: A national cross-sectional cohort study. BMC Pulm. Med. 13, 51. https:\/\/doi.org\/10.1186\/1471-2466-13-51 (2013).","journal-title":"BMC Pulm. Med."},{"key":"13271_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","volume":"14","author":"C Scarpignato","year":"2016","unstructured":"Scarpignato, C. et al. Effective and safe proton pump inhibitor therapy in acid-related diseases\u2014A position paper addressing benefits and potential harms of acid suppression. BMC Med. 14, 179. https:\/\/doi.org\/10.1186\/s12916-016-0718-z (2016).","journal-title":"BMC Med."},{"key":"13271_CR27","doi-asserted-by":"publisher","first-page":"CD011969","DOI":"10.1002\/14651858.CD011969.pub2","volume":"3","author":"TA Boghossian","year":"2017","unstructured":"Boghossian, T. A. et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst. Rev. 3, CD011969. https:\/\/doi.org\/10.1002\/14651858.CD011969.pub2 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"13271_CR28","doi-asserted-by":"publisher","first-page":"e015735","DOI":"10.1136\/bmjopen-2016-015735","volume":"7","author":"Y Xie","year":"2017","unstructured":"Xie, Y. et al. Risk of death among users of proton pump inhibitors: A longitudinal observational cohort study of United States veterans. BMJ Open 7, e015735. https:\/\/doi.org\/10.1136\/bmjopen-2016-015735 (2017).","journal-title":"BMJ Open"},{"key":"13271_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.hlc.2017.10.020","volume":"27","author":"TP Shiraev","year":"2018","unstructured":"Shiraev, T. P. & Bullen, A. Proton pump inhibitors and cardiovascular events: A systematic review. Heart Lung Circ. 27, 443\u2013450. https:\/\/doi.org\/10.1016\/j.hlc.2017.10.020 (2018).","journal-title":"Heart Lung Circ."},{"key":"13271_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13099-021-00414-8","volume":"13","author":"S Alhumaid","year":"2021","unstructured":"Alhumaid, S. et al. Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis. Gut Pathog. 13, 17. https:\/\/doi.org\/10.1186\/s13099-021-00414-8 (2021).","journal-title":"Gut Pathog."},{"key":"13271_CR31","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/j.1365-2036.2011.04874.x","volume":"34","author":"C Bavishi","year":"2011","unstructured":"Bavishi, C. & Dupont, H. L. Systematic review: The use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol. Ther. 34, 1269\u20131281. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04874.x (2011).","journal-title":"Aliment Pharmacol. Ther."},{"key":"13271_CR32","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","volume":"102","author":"J Leonard","year":"2007","unstructured":"Leonard, J., Marshall, J. K. & Moayyedi, P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am. J. Gastroenterol. 102, 2047\u20132056. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01275.x (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"13271_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","volume":"11","author":"WK Lo","year":"2013","unstructured":"Lo, W. K. & Chan, W. W. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: A meta-analysis. Clin. Gastroenterol. Hepatol. 11, 483\u2013490. https:\/\/doi.org\/10.1016\/j.cgh.2012.12.011 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"13271_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","volume":"157","author":"P Moayyedi","year":"2019","unstructured":"Moayyedi, P. et al. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology 157, 682\u2013691. https:\/\/doi.org\/10.1053\/j.gastro.2019.05.056 (2019).","journal-title":"Gastroenterology"},{"key":"13271_CR35","doi-asserted-by":"publisher","first-page":"e1916205","DOI":"10.1001\/jamanetworkopen.2019.16205","volume":"2","author":"AM Vilcu","year":"2019","unstructured":"Vilcu, A. M. et al. Association between acute gastroenteritis and continuous use of proton pump inhibitors during winter periods of highest circulation of enteric viruses. JAMA Netw. Open 2, e1916205. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.16205 (2019).","journal-title":"JAMA Netw. Open"},{"key":"13271_CR36","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.14309\/ajg.0000000000000798","volume":"115","author":"CV Almario","year":"2020","unstructured":"Almario, C. V., Chey, W. D. & Spiegel, B. M. R. Increased risk of COVID-19 among users of proton pump inhibitors. Am. J. Gastroenterol. 115, 1707\u20131715. https:\/\/doi.org\/10.14309\/ajg.0000000000000798 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"13271_CR37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jpeds.2014.12.067","volume":"166","author":"R Rosen","year":"2015","unstructured":"Rosen, R. et al. 16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora. J. Pediatr. 166, 917\u2013923. https:\/\/doi.org\/10.1016\/j.jpeds.2014.12.067 (2015).","journal-title":"J. Pediatr."},{"key":"13271_CR38","doi-asserted-by":"publisher","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","volume":"10","author":"AA Lambert","year":"2015","unstructured":"Lambert, A. A. et al. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: A systematic review and meta-analysis. PLoS ONE 10, e0128004. https:\/\/doi.org\/10.1371\/journal.pone.0128004 (2015).","journal-title":"PLoS ONE"},{"key":"13271_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/gut.33.5.617","volume":"33","author":"JH Wandall","year":"1992","unstructured":"Wandall, J. H. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut 33, 617\u2013621. https:\/\/doi.org\/10.1136\/gut.33.5.617 (1992).","journal-title":"Gut"},{"key":"13271_CR40","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/alr.22297","volume":"9","author":"W Gan","year":"2019","unstructured":"Gan, W. et al. The difference in nasal bacterial microbiome diversity between chronic rhinosinusitis patients with polyps and a control population. Int. Forum Allergy Rhinol. 9, 582\u2013592. https:\/\/doi.org\/10.1002\/alr.22297 (2019).","journal-title":"Int. Forum Allergy Rhinol."},{"key":"13271_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/alr.21934","volume":"7","author":"D Lal","year":"2017","unstructured":"Lal, D. et al. Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy, allergic rhinitis, and chronic rhinosinusitis subjects. Int. Forum Allergy Rhinol. 7, 561\u2013569. https:\/\/doi.org\/10.1002\/alr.21934 (2017).","journal-title":"Int. Forum Allergy Rhinol."},{"key":"13271_CR42","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3389\/fmicb.2015.01532","volume":"6","author":"TV Joss","year":"2015","unstructured":"Joss, T. V. et al. Bacterial communities vary between sinuses in chronic rhinosinusitis patients. Front. Microbiol. 6, 1532. https:\/\/doi.org\/10.3389\/fmicb.2015.01532 (2015).","journal-title":"Front. Microbiol."},{"key":"13271_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40168-017-0266-6","volume":"5","author":"EK Cope","year":"2017","unstructured":"Cope, E. K., Goldberg, A. N., Pletcher, S. D. & Lynch, S. V. Compositionally and functionally distinct sinus microbiota in chronic rhinosinusitis patients have immunological and clinically divergent consequences. Microbiome 5, 53. https:\/\/doi.org\/10.1186\/s40168-017-0266-6 (2017).","journal-title":"Microbiome"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13271-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:08:20Z","timestamp":1669349300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13271-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13271"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13271-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9554"}}